April 10, 2024 11:15 AM EDTUpdated 05:28 PM
People
Deals

Sanofi to di­vest can­cer biotech it bought for $1B, axe 100 staffers in Cal­i­for­nia

Ayisha Sharma

News Reporter

Sanofi is set to di­vest a site and as­sets un­der Amu­nix Phar­ma­ceu­ti­cals, an im­muno-on­col­o­gy biotech it ac­quired for $1 bil­lion around three years ago. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times